Head to Head Pilot Trial of Mailed Cologuard to Mailed FIT
Part of paid clinical trials in La Jolla, California.
- Sponsor
- University of California, San Diego
- Study ID
- NCT06173375
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 45 Years - 49 Years
- Healthy Volunteers
- Not accepted
Interventions
- Cologuard — DIAGNOSTIC_TESTMulti-target stool DNA test for colorectal cancer screening implemented by Exact Sciences. Cologuard has 94% sensitivity and 87% specificity to detect colorectal cancer.
- Fecal Immunochemical Test — DIAGNOSTIC_TESTStool blood test for colorectal cancer screening. FIT has 75% sensitivity and 90% specificity to detect colorectal cancer.
Study Details
The objective of this pilot study is to compare the effectiveness of mailed outreach of two stool based tests, Cologuard and the fecal immunochemical test (FIT) in screening eligible adults ages 45-49 receiving care at the University of California San Diego Health system.
Key Dates
- Start date
- May 15, 2024
- Status verified
- Apr 2026
- Primary completion
- Dec 31, 2024
- Completion
- Dec 31, 2025
Study Design
- Enrollment
- 12 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SCREENING
Arms
- Experimental: Mailed Cologuard OutreachReceipt of mailed Cologuard test for colorectal cancer screening to be completed and returned by participant. If test is negative, participant will be advised to undergo another test in 3 years. If test is positive, participant will be advised to schedule colonoscopy for further testing.
- Active Comparator: Mailed Fecal immunochemical test OutreachReceipt of mailed FIT for colorectal cancer screening to be completed and returned by participant. If test is negative, participant will be advised to undergo another test in 1 year. If test is positive, participant will be advised to schedule colonoscopy for further testing.
Primary Outcome Measure
Number of Participants Completing Colorectal Cancer Screening [ Time Frame: Within 3 months of randomization ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California San Diego | La Jolla | California | 92126 | - |
Find similar trials in La Jolla, CA
By condition
By specialty
By research site
Related Studies
- ColoCare Study - Colorectal Cancer CohortRecruiting · University of Utah · Los Angeles, California
- A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid TumorsPHASE1/PHASE2 · Recruiting · Merus B.V. · La Jolla, California
- Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC FusionsPHASE1/PHASE2 · Recruiting · IDEAYA Biosciences · Los Angeles, California
- Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid MalignanciesPHASE1 · Recruiting · BioEclipse Therapeutics · Scottsdale, Arizona